These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 17419691)

  • 21. Photodynamic therapy for nonmelanoma skin cancers. Current review and update.
    Zeitouni NC; Oseroff AR; Shieh S
    Mol Immunol; 2003 Jul; 39(17-18):1133-6. PubMed ID: 12835091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome.
    Tyrrell JS; Campbell SM; Curnow A
    Lasers Surg Med; 2010 Sep; 42(7):613-9. PubMed ID: 20806386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effective photodynamic therapy of actinic keratoses and Bowen's disease using microneedle perforation.
    Kolde G; Rowe E; Meffert H
    Br J Dermatol; 2013 Feb; 168(2):450-2. PubMed ID: 22804095
    [No Abstract]   [Full Text] [Related]  

  • 24. Photodynamic therapy of non-melanoma skin cancer with methyl aminolaevulinate is associated with less pain than with aminolaevulinic acid.
    Gaál M; Otrosinka S; Baltás E; Ocsai H; Oláh J; Kemény L; Gyulai R
    Acta Derm Venereol; 2012 Mar; 92(2):173-5. PubMed ID: 22113788
    [No Abstract]   [Full Text] [Related]  

  • 25. Risk of acute postoperative hypertension after topical photodynamic therapy for non-melanoma skin cancer.
    Borroni RG; Carugno A; Rivetti N; Arbustini E; Brazzelli V
    Photodermatol Photoimmunol Photomed; 2013 Apr; 29(2):73-7. PubMed ID: 23458390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A cost analysis of photodynamic therapy with methyl aminolevulinate and imiquimod compared with conventional surgery for the treatment of superficial basal cell carcinoma and Bowen's disease of the lower extremities.
    Aguilar M; de Troya M; Martin L; Benítez N; González M
    J Eur Acad Dermatol Venereol; 2010 Dec; 24(12):1431-6. PubMed ID: 20456549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Topical photodynamic therapy in basal and squamous cell carcinoma and penile Bowen's disease with 20% aminolevulinic acid, and exposure to red light and infrared light].
    Harth Y; Hirshovitz B
    Harefuah; 1998 Apr; 134(8):602-5, 672, 671. PubMed ID: 10911421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aminolevulinic acid photodynamic therapy for skin cancers.
    Blume JE; Oseroff AR
    Dermatol Clin; 2007 Jan; 25(1):5-14. PubMed ID: 17126737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photodynamic therapy in the treatment of extensive Bowen's disease.
    López N; Meyer-Gonzalez T; Herrera-Acosta E; Bosch R; Castillo R; Herrera E
    J Dermatolog Treat; 2012 Dec; 23(6):428-30. PubMed ID: 21787214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interventions for cutaneous Bowen's disease.
    Bath-Hextall FJ; Matin RN; Wilkinson D; Leonardi-Bee J
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD007281. PubMed ID: 23794286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methyl aminolevulinate-photodynamic therapy for basal cell carcinoma.
    Szeimies RM
    Dermatol Clin; 2007 Jan; 25(1):89-94. PubMed ID: 17126746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical methyl aminolevulinate.
    Siddiqui MA; Perry CM; Scott LJ
    Am J Clin Dermatol; 2004; 5(2):127-37; discussion 138-40. PubMed ID: 15109276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications - actinic keratoses, Bowen's disease, basal cell carcinoma.
    Morton CA; Szeimies RM; Sidoroff A; Braathen LR
    J Eur Acad Dermatol Venereol; 2013 May; 27(5):536-44. PubMed ID: 23181594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The wider application of photodynamic therapy in dermatology].
    Thissen MR; Kuijpers DI; Neumann HA
    Ned Tijdschr Geneeskd; 2005 Jan; 149(5):232-7. PubMed ID: 15719833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Photodynamic therapy for subungual Bowen's disease.
    Tan B; Sinclair R; Foley P
    Australas J Dermatol; 2004 Aug; 45(3):172-4. PubMed ID: 15250896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group.
    Morton CA; Brown SB; Collins S; Ibbotson S; Jenkinson H; Kurwa H; Langmack K; McKenna K; Moseley H; Pearse AD; Stringer M; Taylor DK; Wong G; Rhodes LE
    Br J Dermatol; 2002 Apr; 146(4):552-67. PubMed ID: 11966684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [PDT panoramic view. Principle, photosensitizers, light sources and validated indications in dermatology].
    Basset-Seguin N
    Ann Dermatol Venereol; 2013 Nov; 140 Suppl 2():223-8. PubMed ID: 24199714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Photodynamic therapy for non-melanoma skin cancer.
    Fien SM; Oseroff AR
    J Natl Compr Canc Netw; 2007 May; 5(5):531-40. PubMed ID: 17509255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The emerging role of 5-ALA-PDT in dermatology: is PDT superior to standard treatments?
    Morton CA
    J Dermatolog Treat; 2002; 13 Suppl 1():S25-9. PubMed ID: 12060514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Photodynamic therapy of nonmelanoma skin cancer with topical hypericum perforatum extract--a pilot study.
    Kacerovská D; Pizinger K; Majer F; Smíd F
    Photochem Photobiol; 2008; 84(3):779-85. PubMed ID: 18179625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.